Concepedia

Kezhi Zhou

KZ

Statistics

Publications

4

Citations

50

H-Index

4

Active since

2022

Affiliations

Nanjing Medical University(Current)

Second Affiliated Hospital of Nanjing Medical University

Wuhan University

Key Laboratory of Nuclear Radiation and Nuclear Energy Technology

Zhongnan Hospital of Wuhan University

Kezhi Zhou is an author at Nanjing Medical University specializing in antibody characterization, renal pharmacotherapy, and clinical remission.

Publications per year

2022–2024

4

Publications

4

Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study

Kezhi Zhou, Junyi Zhou, Le‐Ting Zhou et al. · PLoS ONE · 2024 · 14 citations · Full text

, , +17

NUP153 promotes HCC cells proliferation via c-Myc-mediated downregulation of P15INK4b

Caiqin Gan, Kezhi Zhou, Mengting Li et al. · Digestive and Liver Disease · 2022 · 13 citations

, , +14

PLA2R-IgG4 antibody as a predictive biomarker of treatment effectiveness and prognostic evaluation in patients with idiopathic membranous nephropathy: a retrospective study

Yiqing Huang, Junyi Zhou, Kezhi Zhou et al. · PeerJ · 2022 · 13 citations · Full text

, , +17

Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer

Wenjie Li, Kezhi Zhou, Mengting Li et al. · BMC Gastroenterology · 2022 · 10 citations · Full text

, , +17

1–4 of 4